HGH Fragment 176-191 5MG

HGH Fragment 176-191 5MG is a modified synthetic peptide fragment corresponding to amino acids 176–191 of the C-terminal region of human growth hormone (HGH). In in-vitro laboratory research, this fragment has been studied for its relevance to lipid metabolism investigations, where it has been observed to influence lipolytic (fat-mobilising) activity in isolated adipocyte (fat cell) models without appearing to affect growth or insulin-like signalling pathways associated with the intact HGH molecule. Researchers use the fragment as a tool to explore the structure–function relationships of growth hormone and to characterise the discrete biological activities of its isolated regions under controlled cell-culture conditions. Supplied as a lyophilised research compound of ≥99% purity for in-vitro laboratory use only, with cold-chain dispatch and batch documentation (COA) available on request. Not for human consumption — Research purposes only. Not a dosing or administration guide.